• DESIPRAMINE CHEMBL72 FDA Approved

    Alternate Names:

    Desipramine
    Ratio-desipramine Tab 75mg
    Ratio-desipramine Tab 50mg
    Ratio-desipramine Tab 25mg
    Ratio-desipramine Tab 10mg
    Ratio-desipramine Tab 100mg
    Pertofrane Tab 50mg
    Pertofrane 25mg
    Pertofrane
    Pertofran
    Penta-desipramine Tablets
    PMS-desipramine - Tab 100mg
    PMS Desipramine Hydro Tab 75mg
    PMS Desipramine Hydro Tab 50mg
    PMS Desipramine Hydro Tab 25mg
    PMS Desipramine Hydro Tab 10mg
    PHL-desipramine
    Nu-desipramine - Tab 75mg
    Nu-desipramine - Tab 50mg
    Nu-desipramine - Tab 25mg
    Nu-desipramine - Tab 10mg
    Nu-desipramine - Tab 100mg
    Novo-desipramine Sc -tab 75mg
    Novo-desipramine Sc - Tab 25mg
    Novo-desipramine Sc - Tab 10mg
    Novo-desipramine Fc - 50mg Tab
    Norpramin Tab 75mg
    Norpramin Tab 50mg
    Norpramin Tab 25mg
    Norpramin 75mg Tab
    Norpramin 50mg Tab
    Norpramin 25mg Tab
    Norpramin 10mg Tab
    Norpramin 100mg Tab
    Norpramin
    Dom-desipramine Tablets - 50mg
    Dom-desipramine Tablets - 25mg
    Desipramine-75 - Tab 75mg
    Desipramine-50 - Tab 50mg
    Desipramine-25 - Tab 25mg
    Desipramine-10 - Tab 10mg
    Desipramine Hydrochloride
    50-47-5
    Norimipramine
    N-(3-methylaminopropyl)iminobibenzyl
    Monodemethylimipramine
    Desmethylimipramine
    Desipraminum
    Desipramina
    DMI
    5-(γ-methylaminopropyl)iminodibenzyl
    5-(gamma-Methylaminopropyl)iminodibenzyl
    3-(10,11-DIHYDRO-5H-dibenzo[b,F]azepin-5-yl)-N-methylpropan-1-amine
    DB01151
    IMIPRAMINE, DEMETHYL-
    DESIPRAMINE [INN:BAN]
    IDI1_000190
    LOPAC0_000358
    5H-DIBENZ(B,F)AZEPINE, 10,11-DIHYDRO-5-(3-(METHYLAMINO)PROPYL)-
    DIVK1C_000190
    DMI (PHARMACEUTICAL)
    LS-60421
    BSPBIO_000405
    BRN 1432747
    SPBIO_000042
    3-(5,6-DIHYDROBENZO[B][1]BENZAZEPIN-11-YL)-N-METHYLPROPAN-1-AMINE
    DESIPRAMINE (INN)
    C06943
    NCGC00024375-04
    NINDS_000190
    NCGC00015340-01
    KBIO2_006057
    58-28-6 (HYDROCHLORIDE)
    BSPBIO_002137
    KBIO2_003489
    EINECS 200-040-0
    PENTOFRAN
    NCGC00015340-03
    AKOS001681456
    L001089
    5H-DIBENZ[B,F]AZEPINE-5-PROPANAMINE, 10,11-DIHYDRO-N-METHYL-
    ZERO/006017
    NCGC00015340-10
    STOCK2S-34822
    DIMETHYLIMIPRAMINE
    UNII-TG537D343B
    CAS-58-28-6
    AC1L1EXQ
    2995
    BPBIO1_000447
    NORPRAMINE
    DAP001151
    NCGC00015340-02
    DEZIPRAMINE
    KBIOSS_000921
    PRESTWICK3_000343
    KBIOGR_000928
    MOLPORT-002-051-955
    SERTOFRAN
    SPECTRUM3_000379
    148551
    CID2995
    DB07682
    DESIMPRAMINE
    SPECTRUM_000441
    SPECTRUM5_000833
    (3-(10H,11H-DIBENZO[B,F]AZEPIN-5-YL)PROPYL)METHYLAMINE
    PRESTWICK1_000343
    CCRIS 7091
    HSDB 3052
    SPECTRUM4_000314
    PERTROFANE
    DESIPRAMINUM [INN-LATIN]
    METHYLAMINOPROPYLIMINODIBENZYL
    AC-15977
    STK735144
    CHEBI:47781
    DESIMIPRAMINE
    PRESTWICK2_000343
    DEMETHYLIMIPRAMINE
    DMI 50475
    DESIPRAMINE (D4)
    DESIPRAMINE HCL
    PRESTWICK0_000343
    SPECTRUM2_000091
    DESIPRAMIN
    SPBIO_002326
    AB00053450
    KBIO2_000921
    KBIO3_001357
    10,11-DIHYDRO-5-(3-METHYLAMINOPROPYL)-5H-DIBENZ(B,F)AZEPINE
    KBIO1_000190
    5H-DIBENZ(B,F)AZEPINE-5-PROPANAMINE, 10,11-DIHYDRO-N-METHYL-
    DESIPRAMINA [INN-SPANISH]
    LOPAC-D-3900
    10, 11-DIHYDRO-N-METHYL-5H-DIBEZ[B,F]AZEPINE-5-PROPANAMINE
    D07791
    DSM
    47781
    46504624
    2888
    CNCCCN1C2CCCCC2CCC3C1CCCC3
    0781-1971-01
    2216272
    2399
    PA449233
    35229
    135649758
    COMPOUND 29 [PMID: 15686906]
    (3-{2-AZATRICYCLO[9.4.0.0(3),?]PENTADECA-1(11),3(8),4,6,12,14-HEXAEN-2-YL}PROPYL)(METHYL)AMINE
    [3-(10,11-DIHYDRO-5H-DIBENZO[B,F]AZEPIN-5-YL)PROPYL]METHYLAMINE HYDROCHLORIDE
    3-(10,11-DIHYDRO-5H-DIBENZO[B,F]AZEPIN-5-YL)-N-METHYL-1-PROPANAMINE #
    5H-DIBENZO[B, F]AZEPINE, N-(3-METHYLAMINOPROPYL)-, 10,11-DIHYDRO
    5-(3-METHYLAMINOPROPYL)-10,11-DIHYDRO-5H-DIBENZO[B,F]AZEPINE
    R1868
    KB-232393
    ST052019
    PL004651
    AN-41558
    AK116445
    AJ-26669
    NCGC00015340-13
    NCGC00015340-11
    NCGC00015340-09
    NCGC00015340-08
    NCGC00015340-07
    NCGC00015340-06
    NCGC00015340-05
    NCGC00015340-04
    MCULE-5904286906
    CCG-118231
    SBB002569
    6943AB
    ZINC1530611
    TG537D343B
    HMS3430H03
    BDBM35229
    GTPL2399
    SCHEMBL34384
    N-[3-(10,11-DIHYDRO-5H-DIBENZO[B,F]AZEPIN-5-YL)PROPYL]-N-METHYLAMINE HYDROCHLORIDE
    PERTOFRANE (SALT/MIX)
    PERTOFRAN (SALT/MIX)
    5H-DIBENZ[B,F]AZEPINE, 10,11-DIHYDRO-5-[3-(METHYLAMINO)PROPYL]-
    TREYZAFAGITREG
    PERTROFANEREG
    NORPRAMINREG
    EX-4355
    3-(5,6-DIHYDROBENZO[B][1]BENZAZEPIN-11-YL)-N-METHYL-PROPAN-1-AMINE
    HCYAFALTSJYZDH-UHFFFAOYSA-N
    135650171

    Drug Info:

    FDA Approval Approved before 1982
    Drug Class small molecule
    Drug Indications Antidepressive Agents, Tricyclic
    Drug Categories therapeutic uses
    Drug Categories serotonin modulators
    Drug Categories qtc-prolonging agents (indeterminate risk and risk modifying)
    Drug Categories psychotropic drugs
    Drug Categories psychoanaleptics
    Drug Categories physiological effects of drugs
    Drug Categories pharmacologic actions
    Drug Categories p-glycoprotein/abcb1 inhibitors
    Drug Categories non-selective monoamine reuptake inhibitors
    Drug Categories neurotransmitter uptake inhibitors
    Drug Categories neurotransmitter agents
    Drug Categories nervous system
    Drug Categories molecular mechanisms of pharmacological action
    Drug Categories membrane transport modulators
    Drug Categories heterocyclic compounds, 3-ring
    Drug Categories heterocyclic compounds
    Drug Categories enzyme inhibitors
    Drug Categories dibenzazepines
    Drug Categories cytochrome p-450 cyp3a inhibitors
    Drug Categories cytochrome p-450 cyp2e1 inhibitors
    Drug Categories cytochrome p-450 cyp2d6 substrates
    Drug Categories cytochrome p-450 cyp2d6 inhibitors (moderate)
    Drug Categories cytochrome p-450 cyp2d6 inhibitors
    Drug Categories cytochrome p-450 cyp2c19 substrates
    Drug Categories cytochrome p-450 cyp2c19 inhibitors
    Drug Categories cytochrome p-450 cyp2b6 inhibitors (moderate)
    Drug Categories cytochrome p-450 cyp2b6 inhibitors
    Drug Categories cytochrome p-450 cyp2a6 inhibitors
    Drug Categories cytochrome p-450 cyp1a2 substrates
    Drug Categories combined inhibitors of cyp3a4 and p-glycoprotein
    Drug Categories chemical actions and uses
    Drug Categories central nervous system depressants
    Drug Categories central nervous system agents
    Drug Categories antidepressive agents, tricyclic
    Drug Categories antidepressive agents
    Drug Categories adrenergic uptake inhibitors
    Drug Categories adrenergic agents
    Drug Groups approved
    Drug Type small molecule
    Drug Type drug/small molecule
    ATC n06aa(non-selective monoamine reuptake inhibitors)
    Year of Approval approved before 1982
    Drug Class antidepressive agents, tricyclic
    (3 More Sources)

    Publications:

  • Interaction Types:
    inhibitor

    Interaction Info:
    Specific Action of the Ligand Inhibition
    Endogenous Drug? False
    Direct Interaction? True

    Publications:

  • Interaction Types:
    inhibitor

    Interaction Info:
    Specific Action of the Ligand Inhibition
    Endogenous Drug? False
    Direct Interaction? False

    Publications:

  • Interaction Types:
    inhibitor

    Interaction Info:
    Details of the Assay for Interaction Assay using HEK-293 cells transfected with hSERT
    Specific Action of the Ligand Inhibition
    Endogenous Drug? False

    Publications:

  • Interaction Types:
    n/a

    Interaction Info:
    Trial Name -
    Novel drug target Established target

    Publications:

  • Interaction Types:
    n/a

    Interaction Info:
    Trial Name -
    Novel drug target Established target

    Publications:

  • Interaction Types:
    n/a

    Interaction Info:
    Trial Name -
    Novel drug target Established target

    Publications:

  • Interaction Types:
    n/a

    Interaction Info:
    Trial Name -
    Novel drug target Established target

    Publications:

  • Interaction Types:
    n/a

    Interaction Info:
    Trial Name -
    Novel drug target Established target

    Publications:

  • Interaction Types:
    n/a

    Interaction Info:

    Publications:

  • Interaction Types:
    n/a

    Interaction Info:

    Publications:

  • Interaction Types:
    n/a

    Interaction Info:

    Publications:

  • Interaction Types:
    n/a

    Interaction Info:

    Publications:

    • Version: 12-July-2012

    Alternate Names:
    DESIMIPRAMINE Drug Generic Name
    NORIMIPRAMINE Drug Generic Name
    148551 pubChemSubstance

    Drug Info:
    ATC n06aa(non-selective monoamine reuptake inhibitors)
    Drug Type drug/small molecule

    Publications:

    • Version: 01-August-2011

    Alternate Names:
    DESIPRAMINE Primary Drug Name

    Drug Info:
    Drug Class antidepressive agents, tricyclic
    Year of Approval approved before 1982

    Publications:

    • Version: January-2014

    Alternate Names:

    Drug Info:
    Drug Indications Antidepressive Agents, Tricyclic
    Drug Class small molecule
    FDA Approval Approved before 1982

    Publications:

    • Version: 09-Feb-2016

    Alternate Names:
    DESIPRAMINE pubchem_primary_name
    2995 PubChem CID
    NORIMIPRAMINE Drug Synonym

    Drug Info:

    Publications:

    • Version: 4.3.02 (25-August-2011)

    Alternate Names:
    D07791 Drug Synonym
    10, 11-DIHYDRO-N-METHYL-5H-DIBEZ[B,F]AZEPINE-5-PROPANAMINE Drug Synonym
    LOPAC-D-3900 Drug Synonym

    Drug Info:

    Publications:

    • Version: 27-September-2017

    Alternate Names:
    DESIPRAMINE GuideToPharmacology Ligand Name
    135650171 PubChem Drug SID

    Drug Info:

    Publications:

    • Version: 15-September-2017

    Alternate Names:

    Drug Info:

    Publications: